Cost-Effectiveness of Dementia Prevention Interventions
Open accessAbstract
Background Assessment of cost-effectiveness of interventions to address modifiable risk factors associated with dementia requires estimates of long-term impacts of these interventions which are rarely directly available and must be estimated using a range of assumptions. Objectives To test the cost-effectiveness of dementia prevention measures using a methodology which transparently addresses the many assumptions required to use data from short-term studies, and which readily incorporates sensitivity analyses. Design We explore an approach to estimating cost-effective prices which uses aggregate data including estimated lifetime costs of dementia, both financial and quality of life, and incorporates a range of assumptions regarding sustainability of short- term gains and other parameters. Setting The approach is addressed in the context of the theoretical reduction in a range of risk factors, and in the context of a specific small-scale trial of an internet-based intervention augmented with diet and physical activity consultations. Measurements The principal outcomes were prices per unit of interventions at which interventions were cost-effective or cost-saving. Results Taking a societal perspective, a notional intervention reducing a range of dementia risk-factors by 5% was cost-effective at $A460 per person with higher risk groups at $2,148 per person. The on-line program costing $825 per person was cost-effective at $1,850 per person even if program effect diminished by 75…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Interventions for individual and multiple risks would potentially be cost-effective but scalability is challenging.
“Interventions for individual and multiple risks would potentially be cost-effective but scalability is challenging, (7, 277-279)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [279]
Cites
Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold
Neumann, P. J., Cohen, J. T., & Weinstein, M. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1405158 · Cited by 2,249 · see citing works
Flagged first, then by citations
Research works printed but not linked: 29
- Handels, 2019, Challenges and recommendations for the health-economic evaluation of primary prevention programmes for dementia, Aging & mental health, 23, 53, 10.1080/13607863.2017.1390730 · DOI
- Kivipelto, 2018, World Wide Fingers will advance dementia prevention, Lancet Neurol, 17, 27, 10.1016/S1474-4422(17)30431-3 · DOI
- Nguyen, 2018, Where are we at with model-based economic evaluations of interventions for dementia? a systematic review and quality assessment, International psychogeriatrics, 30, 1593, 10.1017/S1041610218001291 · DOI
- Meeuwsen, 2013, Cost-effectiveness of one year dementia follow-up care by memory clinics or general practitioners: economic evaluation of a randomised controlled trial, PloS one., 8, e79797-e, 10.1371/journal.pone.0079797 · DOI
- Green, 2019, Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework, Alzheimer's & dementia: the journal of the Alzheimer's Association, 15, 1309, 10.1016/j.jalz.2019.05.004 · DOI
- Lin, 2014, Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer's disease, Health affairs (Project Hope), 33, 547, 10.1377/hlthaff.2013.1276 · DOI
- Tsiachristas, 2016, B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true?, Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2, 156, 10.1016/j.trci.2016.07.002 · DOI
- van Baal, 2016, Preventing dementia by promoting physical activity and the long-term impact on health and social care expenditures, Preventive medicine, 85, 78, 10.1016/j.ypmed.2016.01.013 · DOI
- Zhang, 2011, Cost-effectiveness of a health intervention program with risk reductions for getting demented: results of a Markov model in a Swedish/Finnish setting, Journal of Alzheimer's disease: JAD, 26, 735, 10.3233/JAD-2011-110065 · DOI
- Ashby-Mitchell, 2017, Proportion of dementia in Australia explained by common modifiable risk factors, Alzheimer's Research & Therapy, 9, 11, 10.1186/s13195-017-0238-x · DOI
- Anstey, 2020, Internet-based Intervention Augmented with Diet and Physical Activity Consultation to Decrease Risk of Dementia in At-risk Adults in a Primary Care Setting: Pragmatic Randomized Controlled Trial, Journal of Medical Internet Research, 10.2196/19431 · DOI
- Wang, 2018, Comparing the ICERs in Medicine Reimbursement Submissions to NICE and PBAC—Does the Presence of an Explicit Threshold Affect the ICER Proposed?, Value in Health, 21, 938, 10.1016/j.jval.2018.01.017 · DOI
- Brodaty, 2012, Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia, International psychogeriatrics, 24, 1034, 10.1017/S1041610211002924 · DOI · Paper page
- Sachs, 2011, Cognitive impairment: an independent predictor of excess mortality: a cohort study, Annals of internal medicine, 155, 300, 10.7326/0003-4819-155-5-201109060-00007 · DOI
- Savva, 2015, Who has undiagnosed dementia? A cross-sectional analysis of participants of the Aging, Demographics and Memory Study, Age and Ageing, 44, 642, 10.1093/ageing/afv020 · DOI
- Jutkowitz, 2017, Societal and Family Lifetime Cost of Dementia: Implications for Policy, J Am Geriatr Soc, 65, 2169, 10.1111/jgs.15043 · DOI · Paper page
- Gnanamanickam, 2018, Direct health and residential care costs of people living with dementia in Australian residential aged care, International journal of geriatric psychiatry, 33, 859, 10.1002/gps.4842 · DOI
- Haaksma, 2020, Survival time tool to guide care planning in people with dementia, Neurology, 94, e538, 10.1212/WNL.0000000000008745 · DOI · Paper page
- Strand, 2018, Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway, PloS one, 13, e0204436, 10.1371/journal.pone.0204436 · DOI
- Orgeta, 2015, The use of the EQ-5D as a measure of health-related quality of life in people with dementia and their carers, Qual Life Res, 24, 315, 10.1007/s11136-014-0770-0 · DOI
- Attema, 2018, Discounting in Economic Evaluations, Pharmacoeconomics, 36, 745, 10.1007/s40273-018-0672-z · DOI
- Devlin, 2020, Health today versus health tomorrow: does Australia really care less about its future health than other countries do?, Aust Health Rev, 44, 337, 10.1071/AH20057 · DOI
- Plassman, 2011, Incidence of dementia and cognitive impairment, not dementia in the United States, Ann Neurol, 70, 418, 10.1002/ana.22362 · DOI
- Brinks, 2013, Age of onset in chronic diseases: new method and application to dementia in Germany, Population Health Metrics, 11, 6, 10.1186/1478-7954-11-6 · DOI
- Wolters, 2019, Life Expectancy With and Without Dementia: A Population-Based Study of Dementia Burden and Preventive Potential, Am J Epidemiol, 188, 372, 10.1093/aje/kwy234 · DOI
- Anstey, 2014, A self-report risk index to predict occurrence of dementia in three independent cohorts of older adults: the ANU-ADRI, PloS one, 9, e86141, 10.1371/journal.pone.0086141 · DOI
- Cherbuin, 2019, Validated Alzheimer's Disease Risk Index (ANU-ADRI) is associated with smaller volumes in the default mode network in the early 60s, Brain imaging and behavior, 13, 65, 10.1007/s11682-017-9789-5 · DOI
- Richard, 2012, Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI), Journal of the neurological sciences, 322, 64, 10.1016/j.jns.2012.06.012 · DOI · Paper page
- Clare, 2015, The Agewell trial: a pilot randomised controlled trial of a behaviour change intervention to promote healthy ageing and reduce risk of dementia in later life, BMC Psychiatry, 15, 25, 10.1186/s12888-015-0402-4 · DOI
Cited by
Sorted by citations
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860 · see citing works
Mukadam, N., Anderson, R., Walsh, S., Wittenberg, R., Knapp, M., Brayne, C., & Livingston, G. (2024) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(24)00117-x · Cited by 24 · see citing works
- Authors
- McRae, I., Zheng, L., Bourke, S., Cherbuin, N., & Anstey, K. J.
- Affiliations
- Australian National University (AU)
- UNSW Sydney (AU)
- Corresponding author
- McRae, Ian
- Venue
- The Journal of Prevention of Alzheimer's Disease
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 8
- Issue
- 2
- Pages
- 210-217
- ISSN
- 2274-5807 (ISSN-L)
- OpenAlex
- W3116684053
- Cited by
- 28
- References
- 1
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 6 · 2023: 4 · 2022: 5 · 2021: 1
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The Journal of Prevention of Alzheimer s Disease (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Funders
- Dementia Centre for Research Collaboration
- Medical Research Council
- National Health and Medical Research Council (1100579, 1102694)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dementia prevention, cost-effectiveness, modifiable risk factors, online intervention, quality of life, intervention sustainability, sensitivity analysis, societal perspective
- MeSH terms
- Cost-Benefit Analysis, Delivery of Health Care, Dementia, Humans, Quality of Life, Exercise, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review